COVID-19 is an emerging, rapidly evolving situation.
Eli Lilly funds US-Russia science forum
October 2010 | Volume 9, Issue 5
Photo by Jeff Gray
A forum to advance scientific collaborations between U.S. and Russian scientists has been kicked off with a donation from Eli Lilly and Company.
The U.S.-Russia Forum is being established through the Foundation for NIH, with a $1.27 million gift from Eli Lilly as the founding private partner, and Fogarty and the NIH Clinical Center as the lead U.S. participants. The public-private partnership is intended to facilitate collaboration that will improve public health by strengthening activities related to disease control, treatment and prevention; clinical and translational research; manufacturing practices and regulatory science; and emerging technologies in the field of health care.
The partnership will sponsor a clinical and translational research training program in Russia. There will also be additional resources for Russian scientists who are accepted into the NIH Visiting Fellows Program.
Forum activities will include an annual symposium and will enhance scientific collaborations through joint research proposal development, scientific exchanges and research conferences.
The U.S.-Russia Forum in Health Sciences is intended to include participants from both public and private sector organizations engaged in biomedical and behavioral research and development.
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.
Related World Regions / Countries